C-suite leaders and other executives from EHR, analytics, clinical automation and managed services firms see enforcement of the new Cures Act final rule as an overdue “step in the right direction.” News from healthcareitnews.com
C-suite leaders and other executives from EHR, analytics, clinical automation and managed services firms see enforcement of the new Cures Act final rule as an overdue “step in the right direction.”
